Mynd.ai, Inc. (MYND:NYSEMKT) closed at $0.240 on October 23, 2026, up 47.42% on the day. The stock trades 66.7% below its 52-week high of $0.720 and 49.1% above its 52-week low of $0.161. Over the past year, it lost 65.7%. Mynd.ai, Inc. is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, MYND closed higher on 100 days (40%). Its best day was May 29, 2026 (+114.34%) and its worst was June 1, 2026 (-34.75%). The stock moved 10% or more in a single session 23 times. It opened at least 5% above the previous day's high 10 times.
MYND Life Sciences Inc is a life science based, neuro-pharmaceutical drug development company. It is advancing medicines based on neuro-anti-inflammatory substances through rigorous science with an initial focus on major depressive disorder. The company's mission is to further research linking depression and inflammation at the genetic and cellular level to develop a pharmaceutical treatment utilizing compounds found in psychedelics with the initial focus being on psilocybin and its various analogs.
Find more stocks like MYND with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.